Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1-(2H-1,3-benzodioxol-5-yl)cyclobutane-1-carboxylic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

202737-28-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 202737-28-8 Structure
  • Basic information

    1. Product Name: 1-(2H-1,3-benzodioxol-5-yl)cyclobutane-1-carboxylic acid
    2. Synonyms: 1-(2H-1,3-benzodioxol-5-yl)cyclobutane-1-carboxylic acid;1-(1,3-BENZODIOXOL-5-YL)-CYCLOBUTANECARBOXYLIC ACID;1-(BENZO[D][1,3]DIOXOL-6-YL)CYCLOBUTANECARBOXYLIC ACID
    3. CAS NO:202737-28-8
    4. Molecular Formula: C12H12O4
    5. Molecular Weight: 220.223
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 202737-28-8.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 1-(2H-1,3-benzodioxol-5-yl)cyclobutane-1-carboxylic acid(CAS DataBase Reference)
    10. NIST Chemistry Reference: 1-(2H-1,3-benzodioxol-5-yl)cyclobutane-1-carboxylic acid(202737-28-8)
    11. EPA Substance Registry System: 1-(2H-1,3-benzodioxol-5-yl)cyclobutane-1-carboxylic acid(202737-28-8)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 202737-28-8(Hazardous Substances Data)

202737-28-8 Usage

Chemical class

Cyclobutane derivative containing a benzodioxole ring

Molecular weight

232.236 g/mol

Potential applications

Pharmaceutical industry
Anti-inflammatory properties
Analgesic properties
Development of new drugs in medicinal chemistry

Chemical structure

Interesting candidate for further research and development in the pharmaceutical industry
These properties highlight the importance of 1-(2H-1,3-benzodioxol-5-yl)cyclobutane-1-carboxylic acid as a potential compound for pharmaceutical applications, particularly in the development of anti-inflammatory and analgesic drugs. Its unique chemical structure also makes it a promising candidate for further research in the field of medicinal chemistry.

Check Digit Verification of cas no

The CAS Registry Mumber 202737-28-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,2,7,3 and 7 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 202737-28:
(8*2)+(7*0)+(6*2)+(5*7)+(4*3)+(3*7)+(2*2)+(1*8)=108
108 % 10 = 8
So 202737-28-8 is a valid CAS Registry Number.

202737-28-8Upstream product

202737-28-8Downstream Products

202737-28-8Relevant articles and documents

Method of treating addiction or dependence using a ligand for a monoamine receptor or transporter

-

, (2008/06/13)

One aspect of the present invention relates to a method of treating of drug addiction or drug dependence in a mammal, comprising the step of administering to a mammal in need thereof a therapuetically effective amount of a heterocyclic compound, e.g., a 3-substituted piperidine. In a preferred embodiment, the method of the present invention treats cocaine addiction or methamphetamine addiction.

Ligands for monoamine receptors and transporters, and methods of use thereof

-

, (2008/06/13)

One aspect of the present invention relates to heterocyclic compounds. A second aspect of the present invention relates to the use of the heterocyclic compounds as ligands for various mammalian cellular receptors, including dopamine, serotonin, or norepinephrine transporters. The compounds of the present invention will find use in the treatment of numerous ailments, conditions and diseases which afflict mammals, including but not limited to addiction, anxiety, depression, sexual dysfunction, hypertension, migraine, Alzheimer's disease, obesity, emesis, psychosis, schizophrenia, Parkinson's disease, inflammatory pain, neuropathic pain, Lesche-Nyhane disease, Wilson's disease, and Tourette's syndrome. An additional aspect of the present invention relates to the synthesis of combinatorial libraries of the heterocyclic compounds, and the screening of those libraries for biological activity, e.g., in assays based on dopamine transporters.

Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation

-

, (2008/06/13)

PCT No. PCT/SE97/01310 Sec. 371 Date Apr. 12, 1999 Sec. 102(e) Date Apr. 12, 1999 PCT Filed Jul. 23, 1997 PCT Pub. No. WO98/04517 PCT Pub. Date Feb. 5, 1998This invention relates to the use of 2-(diisopropylamino)-ethyl-1-phenyl-cyclopentane-carboxylate or 2-(diisopropylamino)-ethyl-1-phenyl-cyclohexane-carboxylate, or a pharmaceutically accceptable salt thereof, for treatment of urinary incontinence or irritable bowel syndrome (IBS).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 202737-28-8